VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer

S. Hart, V. Novotny-Diermayr, K. C. Goh, M. Williams, Y. C. Tan, L. C. Ong, A. Cheong, B. K. Ng, C. Amalini, B. Madan, H. Nagaraj, R. Jayaraman, K. M. Pasha, K. Ethirajulu, W. J. Chng, N. Mustafa, B. C. Goh, C. Benes, U. McDermott, M. Garnett, B. Dymock, J. M. Wood
  • Molecular Cancer Therapeutics, December 2012, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1535-7163.mct-12-0466

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1158/1535-7163.mct-12-0466

The following have contributed to this page: Dr veronica diermayr